Literature DB >> 1651383

PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report.

S Pappata1, P Cornu, Y Samson, C Prenant, J Benavides, B Scatton, C Crouzel, J J Hauw, A Syrota.   

Abstract

The utility of the peripheral type benzodiazepine site ligand 11C-PK 11195, for imaging human glioma in conjunction with Positron Emission Tomography, relies on a high specific binding of the tracer to tumoral peripheral type benzodiazepines sites. In a patient with glioblastoma, we found that 11C-PK 11195 binding was two-fold higher in the tumor than in normal gray matter and that 30% of tumoral binding could be displaced by a large excess of unlabeled drug. These findings suggest that tumoral retention of the ligand is due, in part, to specific binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651383

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  37 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.

Authors:  Pablo M Rusjan; Alan A Wilson; Peter M Bloomfield; Irina Vitcu; Jeffrey H Meyer; Sylvain Houle; Romina Mizrahi
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

3.  TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

Authors:  Nathalie L Albert; M Unterrainer; D F Fleischmann; S Lindner; F Vettermann; A Brunegraf; L Vomacka; M Brendel; V Wenter; C Wetzel; R Rupprecht; J-C Tonn; C Belka; P Bartenstein; M Niyazi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

4.  TSPO PET using 18F-GE-180: a new perspective in neurooncology?

Authors:  Karl-Josef Langen; Antje Willuweit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-12       Impact factor: 9.236

5.  TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.

Authors:  Yihui Chen; Munawwar Sajjad; Yanfang Wang; Carrie Batt; Hani A Nabi; Ravindra K Pandey
Journal:  ACS Med Chem Lett       Date:  2010-11-23       Impact factor: 4.345

6.  Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods.

Authors:  N Miyazawa; E Hamel; M Diksic
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

7.  Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study.

Authors:  P Cornu; J Benavides; B Scatton; J J Hauw; J Philippon
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Myocardial accumulation of a dopamine D2 receptor-binding radioligand, 2'-iodospiperone.

Authors:  H Saji; Y Yonekura; K Tanahashi; Y Iida; Y Iwasaki; Y Magata; J Konishi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

9.  Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors.

Authors:  Masao Imaizumi; Emmanuelle Briard; Sami S Zoghbi; Jonathan P Gourley; Jinsoo Hong; Yota Fujimura; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

10.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.

Authors:  Masahiro Fujita; Masao Imaizumi; Sami S Zoghbi; Yota Fujimura; Amanda G Farris; Tetsuya Suhara; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2007-11-22       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.